
FAVIBEST
FavipiravirFavipiravir (6-Fluoro-3-hydroxypyrazine-2-carboxamide) is a modified pyrazine analog that was initially approved for therapeutic use in resistant cases of influenza. Not only does favipiravir inhibit replication of influenza A and B, but the drug has shown promise in the treatment of avian influenza, and may be an alternative option for influenza strains that are resistant to…
Know More